TB Research

Molecular Epidemiology of Drug-Resistant Mycobacterium Tuberculosis in Japan

Fuminori Mizukoshi, Nobuyuki Kobayashi, Fumiko Kirikae, Ken Ohta, Kazunari Tsuyuguchi, Noritaka Yamada, Yoshikazu Inoue, Masahide Horiba, et al. (14 authors)

mSphere · 2021-07

Abstract

The incidence rate of tuberculosis (TB) in Japan was 11.5 per 100,000 of the population in 2019. Of TB patients in Japan, 61.1% were aged >70 years, and 10.7% were born outside Japan, mostly in Asian countries with a high burden of tuberculosis. Of the tuberculosis patients in the present study, 5.4% and 1.0% showed resistance to isoniazid and rifampicin, respectively, and 0.7% were multidrug resistant. The objective of this study was to clarify the molecular epidemiological properties of drug-resistant tuberculosis in Japan. Molecular epidemiology provides several clues to inform potential measures to control drug-resistant tuberculosis in Japan.

MeSH terms

  • Tuberculosis
  • Rifampicin
  • Isoniazid
  • Mycobacterium tuberculosis
  • Drug resistance
  • Medicine
  • Multiple drug resistance
  • Population
  • Molecular epidemiology
  • Epidemiology
  • Virology
  • Biology
  • Microbiology